RxDoctor Payments Data

Mara Roth, MD

Endocrinology, Diabetes & Metabolism · Seattle, WANPI 1992997332

Payments from drug & device makers

What this record shows

That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in WA, where the typical reported total is $728.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$355,722in research payments, 2019–2025

Across 35 payments — averaging $10,163 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Exelixis Inc.$356K

How this compares

$0 in reported general payments places this provider in the 0th percentile of 161 endocrinology, diabetes & metabolism providers in Washington.

See all endocrinology, diabetes & metabolism providers in Washington

Medicare billing

Part B allowed, 2024
$24,356
Medicare patients
132
Services billed
297

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SynthroidLevothyroxine Sodium36$3,879
Levothyroxine Sodium322$3,505
Hydrocortisone62$3,091
Liothyronine Sodium14$844
Calcitriol11$721
Methimazole13$236

Paid to pharmacies, not to this prescriber.

Other endocrinology, diabetes & metabolism in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →